Integration of Pharmacometrics and Pharmacoeconomics to Quantify the Value of Improved Forgiveness to Nonadherence: A Case Study of Novel Xanthine Oxidase Inhibitors for Gout. (2019)

First Author: Hill-McManus D
Attributed to:  Renewal of the Network of Hubs for Trials Methodology Research. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/cpt.1454

PubMed Identifier: 30993686

Publication URI: http://europepmc.org/abstract/MED/30993686

Type: Journal Article/Review

Volume: 106

Parent Publication: Clinical pharmacology and therapeutics

Issue: 3

ISSN: 0009-9236